Zacks Research Downgrades Croda International (OTCMKTS:COIHY) to Strong Sell

Croda International (OTCMKTS:COIHY) was downgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Tuesday,Zacks.com reports.

Separately, Kepler Capital Markets upgraded shares of Croda International from a “reduce” rating to a “hold” rating in a report on Tuesday, March 31st. One analyst has rated the stock with a Strong Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Croda International currently has a consensus rating of “Hold”.

Croda International Stock Performance

Shares of COIHY traded up $0.16 during mid-day trading on Tuesday, hitting $19.31. 734 shares of the company’s stock were exchanged, compared to its average volume of 21,752. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.99 and a quick ratio of 1.18. Croda International has a 52 week low of $16.26 and a 52 week high of $22.29. The company has a 50-day simple moving average of $19.35 and a 200 day simple moving average of $18.97.

Croda International Company Profile

Croda International plc is a UK-based specialty chemicals company headquartered in East Yorkshire, England. Established in 1925, Croda has built a global reputation for developing and manufacturing high-performance ingredients derived primarily from natural oils and renewable resources. The company’s research-driven approach has enabled it to innovate across a wide range of sectors, delivering solutions that combine efficacy, sustainability and compliance with stringent regulatory standards.

Croda’s operations are organized around three core segments: Personal Care, Life Sciences and Performance Technologies.